46
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Performance Characteristics of the Cepheid Xpert MTB/RIF Test in a Tuberculosis Prevalence Survey

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Background

          Xpert MTB/RIF (“Xpert”) is a molecular test for detection of Mycobacterium tuberculosis (MTB) in sputum. Performance characteristics have been established for its use during passive tuberculosis (TB) case detection in symptomatic TB suspects, but Xpert performance has not been assessed in other settings. Objectives were to determine Xpert performance and costs in the context of a TB prevalence survey.

          Methodology/Principal Findings

          This was a diagnostic sub-study of a TB prevalence survey conducted in gold mining companies in South Africa. Sputa (one per participant) were tested using smear microscopy, liquid culture (reference comparator), and Xpert. Costs were collected using an ingredients approach and analyzed using a public health program perspective. 6893 participants provided a sputum specimen. 187/6893 (2.7%) were positive for MTB in culture, 144/6893 (2.1%) were positive for MTB by Xpert, and 91/6893 (1.3%) were positive for acid fast bacilli by microsocopy. Sensitivity, specificity, positive predictive value, and negative predictive value for detection of MTB by Xpert were 62.6% (95% confidence interval [CI] 55.2, 69.5), 99.6% (99.4, 99.7), 81.3% (73.9, 87.3), and 98.9 (98.6, 98.8); agreement between Xpert and culture was 98.5% (98.2, 98.8). Sensitivity of microscopy was 17.6% (12.5, 23.9). When individuals with a history of TB treatment were excluded from the analysis, Xpert specificity was 99.8 (99.7, 99.9) and PPV was 90.6 (83.3, 95.4) for detection of MTB. For the testing scenario of 7000 specimens with 2.7% of specimens culture positive for MTB, costs were $165,690 for Xpert and $115,360 for the package of microscopy plus culture.

          Conclusion

          In the context of a TB prevalence survey, the Xpert diagnostic yield was substantially higher than that of microscopy yet lower than that of liquid culture. Xpert may be useful as a sole test for TB case detection in prevalence surveys, particularly in settings lacking capacity for liquid culture.

          Related collections

          Most cited references1

          • Record: found
          • Abstract: found
          • Article: not found

          Clinical diagnosis of smear-negative pulmonary tuberculosis in low-income countries: the current evidence.

          Sputum smear examination for acid-fast bacilli (AFB) can diagnose up to 50-60% of cases of pulmonary tuberculosis in well-equipped laboratories. In low-income countries, poor access to high-quality microscopy services contributes to even lower rates of AFB detection. Furthermore, in countries with high prevalence of both pulmonary tuberculosis and HIV infection, the detection rate is even lower owing to the paucibacillary nature of pulmonary tuberculosis in patients with HIV infection. In the absence of positive sputum smears for AFB, at primary care level, most cases of pulmonary tuberculosis are diagnosed on the basis of clinical and radiological indicators. This review aims to evaluate various criteria, algorithms, scoring systems, and clinical indicators used in low-income countries in the diagnosis of pulmonary tuberculosis in people with suspected tuberculosis but repeated negative sputum smears. Several algorithms and clinical scoring systems based on local epidemiology have been developed to predict smear-negative tuberculosis. Few of these have been validated within the local context. However, in areas where smear-negative tuberculosis poses a major public-health problem, these algorithms may be useful to national tuberculosis programmes by providing a starting point for development their own context-specific diagnostic guidelines.
            Bookmark

            Author and article information

            Contributors
            Role: Editor
            Journal
            PLoS One
            PLoS ONE
            plos
            plosone
            PLoS ONE
            Public Library of Science (San Francisco, USA )
            1932-6203
            2012
            15 August 2012
            : 7
            : 8
            : e43307
            Affiliations
            [1 ]Johns Hopkins University School of Medicine, Baltimore, Maryland, United States of America
            [2 ]Aurum Institute for Health Research, Johannesburg, South Africa
            [3 ]London School of Hygiene and Tropical Medicine, London, United Kingdom
            [4 ]School of Public Health, University of Witwatersrand, Johannesburg, South Africa
            Institute of Infectious Diseases and Molecular Medicine, South Africa
            Author notes

            Competing Interests: The authors have declared that no competing interests exist.

            Conceived and designed the experiments: SED VNC MS DC ADG GJC KLF. Performed the experiments: VNC MS. Analyzed the data: JJL KLF SED VNC MS ADG GJC. Contributed reagents/materials/analysis tools: GJC. Wrote the paper: SED VNC MS DC GJC KLF. Revised the manuscript for important intellectual content and approved the final manuscript version: SED VNC JJL MS DC ADG GJC KLF.

            Article
            PONE-D-12-13900
            10.1371/journal.pone.0043307
            3419700
            22905254
            30ce5578-ee24-4e7c-b707-c2a3538d3caa
            Copyright @ 2012

            This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

            History
            : 12 May 2012
            : 23 July 2012
            Page count
            Pages: 8
            Funding
            This work was supported by grants from the U.S. National Institutes of Health (RO1 AI51528, 5U2RTW007370, and 5U2RTW007373) and the Bill and Melinda Gates Foundation. Katherine Fielding was partially funded and James Lewis fully funded by the Biostatistics core of the Consortium to Respond Effectively to the AIDS and TB Epidemics (CREATE) with a grant from the Bill and Melinda Gates Foundation. The Foundation for Innovative New Diagnostics provided Xpert MTB/RIF cartridges at a reduced concessionary price. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
            Categories
            Research Article
            Medicine
            Diagnostic Medicine
            Test Evaluation
            Infectious Diseases
            Bacterial Diseases
            Tuberculosis
            Non-Clinical Medicine
            Health Care Policy
            Health Statistics
            Health Informatics
            Health Services Research
            Public Health
            Health Screening

            Uncategorized
            Uncategorized

            Comments

            Comment on this article